Breaking News

Alcami, Solasia Enter API Mfg. Pact

To manufacture Solasia's Darinaparsin API at CoE in Germantown, WI

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Alcami, a provider of custom development and manufacturing services, has finalized manufacturing and quality agreements with Solasia Pharma, K.K. for the clinical supply manufacture of the active pharmaceutical ingredient (API) darinaparsin, a mitochondrial-targeted agent developed for the treatment of various hematologic and solid cancers.  Process development for darinaparsin and clinical manufacturing will begin in 4Q17 at Alcami’s new highly potent API suites at its Center of Excell...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters